Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
36.38B | 35.55B | 33.87B | 31.32B | 30.83B | Gross Profit |
8.49B | 8.47B | 8.18B | 7.41B | 7.27B | EBIT |
4.35B | 4.21B | 4.03B | 3.37B | 3.34B | EBITDA |
4.58B | 4.44B | 4.32B | 3.62B | 3.66B | Net Income Common Stockholders |
3.05B | 2.92B | 2.79B | 2.28B | 2.29B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
27.13B | 24.04B | 24.20B | 21.53B | 21.43B | Total Assets |
50.81B | 48.17B | 46.82B | 44.31B | 42.81B | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-25.63B | -23.04B | -22.70B | -20.53B | -20.43B | Total Liabilities |
8.95B | 8.39B | 8.70B | 8.12B | 7.93B | Stockholders Equity |
41.86B | 39.78B | 38.12B | 36.19B | 34.87B |
Cash Flow | Free Cash Flow | |||
4.59B | 2.91B | 2.77B | 2.13B | 2.90B | Operating Cash Flow |
4.71B | 2.95B | 2.93B | 2.24B | 3.00B | Investing Cash Flow |
-1.14B | -1.34B | -57.84M | 342.11M | 93.67M | Financing Cash Flow |
-983.76M | -1.26B | -703.42M | -983.52M | -702.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥45.63B | 14.28 | 7.42% | 3.92% | 3.60% | 3.26% | |
74 Outperform | ¥1.29T | 28.74 | 1.73% | 24.10% | 11.27% | ||
73 Outperform | €637.47B | 29.18 | 15.61% | 0.43% | 6.23% | 78.16% | |
73 Outperform | $5.80T | 26.08 | 11.70% | 0.83% | -5.48% | -11.96% | |
66 Neutral | $1.09T | 19.30 | 16.17% | 2.62% | 15.49% | 18.42% | |
65 Neutral | $4.15T | 28.34 | 7.94% | 0.50% | 7.95% | 14.53% | |
60 Neutral | $10.94B | 10.37 | -6.73% | 2.98% | 7.75% | -12.61% |